AI startup Perplexity makes bold $44b bid for Google's Chrome browser
Perplexity AI did not disclose how it plans to fund the offer for Google's Chrome browser.
NEW YORK - Perplexity AI made a US$34.5 billion (S$44.2 billion) unsolicited all-cash offer for Alphabet's Chrome browser on Aug 12, a bid far above its own valuation as the startup reaches for the browser's billions of users pivotal to the AI search race.
Run by Mr Aravind Srinivas, Perplexity is no stranger to headline-grabbing offers: it made
a similar one for TikTok US in January, offering to merge with the popular short-video app to resolve US concerns about TikTok's Chinese ownership.
OpenAI, Yahoo and private-equity firm Apollo Global Management have also expressed interest in Chrome as
regulatory pressure threatens Google's grip on the industry.
Google did not immediately respond to Reuters requests for comment.
The company has not offered Chrome for sale and
plans to appeal a US court ruling in 2024 that found it held an unlawful monopoly in online search.
The Justice Department has sought a Chrome divestiture as part of the case's remedies.
Perplexity did not disclose on Aug 12 how it plans to fund the offer.
Top stories
Swipe. Select. Stay informed.
Singapore Luxury items seized in $3b money laundering case handed over to Deloitte for liquidation
Singapore MyRepublic customers air concerns over broadband speed after sale to StarHub
Singapore Power switchboard failure led to disruption in NEL, Sengkang-Punggol LRT services: SBS Transit
Singapore NEL and Sengkang-Punggol LRT resume service after hours-long power fault
Business Ninja Van cuts 12% of Singapore workforce after 2 rounds of layoffs in 2024
Singapore Hyflux investigator 'took advantage' of Olivia Lum's inability to recall events: Davinder Singh
Singapore Man who stabbed son-in-law to death in Boon Tat Street in 2017 dies of heart attack, says daughter
Singapore Man who stalked woman blasted by judge on appeal for asking scandalous questions in court
The three-year-old company has raised around US$1 billion in funding so far from investors including Nvidia and Japan's SoftBank. It was last valued at $14 billion.
Multiple funds have offered to finance the deal in full, Perplexity said, without naming the funds. Alphabet's shares were up 1.6 per cent in afternoon trading.
As a new generation of users turns to chatbots such as ChatGPT and Perplexity for answers, web browsers are regaining prominence as vital gateways to search traffic and prized user data, making them central to Big Tech's AI ambitions.
Perplexity already has an AI browser, Comet, that can perform certain tasks on a user's behalf and buying Chrome would allow it to tap the browser's more than three billion users, giving it the heft to better compete with bigger rivals such as OpenAI.
The ChatGPT parent is also working on its own AI browser.
Perplexity's bid pledges to keep the underlying browser code called Chromium open source, invest US$3 billion over two years and make no changes to Chrome's default search engine, according to a term sheet seen by Reuters.
The company said the offer, with no equity component, would preserve user choice and ease future competition concerns.
Analysts have said Google would be unlikely to sell Chrome and would likely engage in a long legal fight to prevent that outcome, given it is crucial to the company's AI push as it rolls out features including AI-generated search summaries, known as Overviews, to help defend its search market share.
Federal judge Amit Mehta is expected to issue a ruling on remedies in the Google search antitrust case sometime this month.
'Judge Mehta is a pretty orthodox guy. It's very possible that he would hold off on requiring a sale until the appeals process is worked out and that could be a very lengthy period of time,' said Professor Herbert Hovenkamp, of the University of Pennsylvania Carey Law School.
'It would go to the DC Circuit, which is skeptical of forced divestitures, and it's possible it would even go to the Supreme Court after that. So that process could run out for a couple of years.'
Perplexity's bid is also below the at least US$50 billion value that rival search engine DuckDuckGo's chief executive officer, Mr Gabriel Weinberg, suggested Chrome may command if Google was forced to sell it. REUTERS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
35 minutes ago
- Straits Times
In Your Opinion Podcast: How Gen AI like ChatGPT enhances critical thinking, instead of making people lazy
Sign up now: Get ST's newsletters delivered to your inbox Shahrman Nayan, creative director of OneDash22 in the ST podcast studio. Synopsis: Every month, The Straits Times takes a hard look at Singapore's social issues of the day with guests. Preliminary findings from a recent MIT study in June in the US, concluded that people using just generative AI (Gen AI) tools such as ChatGPT, became lazier with each subsequent essay they wrote. The study, conducted in Boston, categorised three groups of test subjects aged 18 to 39 according to the tools that they used: ChatGPT, Google or no tools. The brain activity of these writers were scanned across 32 regions of their brain. The result found that ChatGPT users had the lowest brain activity, and 'consistently underperformed at neural, linguistic, and behavioural levels,' according to the study. But the way ChatGPT is used was critical, as the study found that test subjects who used ChatGPT only after writing the essays on their own, had significant increases in brain connectivity. Just how can ChatGPT be used to enhance productivity without making us lazy? In this episode, ST assistant podcast editor Lynda Hong unpacks the issues and looks at how her human guests maintain the balance between optimising the use of ChatGPT and becoming over-reliant on it. Her guests are Shahrman Nayan, creative director of OneDash22, a local video production company and an avid user of Gen AI for his work; and Cheryl Chia, founder of BrainFit, an education centre for children and young adults, building their cognitive, thinking, and study skills through programmes grounded in scientific approaches. Top stories Swipe. Select. Stay informed. Singapore NEL, SPLRT disruption: Electricity surge shut down backup power switchboard, says LTA Singapore At least 1 dead after fire in Jalan Bukit Merah flat, about 60 evacuated Singapore HSA seeks Kpod investigators to arrest abusers, conduct anti-trafficking ops Opinion The 30s are heavy: Understanding suicide among Singapore's young adults Singapore Lawyer who sent misleading letters to 22 doctors fails in bid to quash $18,000 penalty Singapore Jail, caning for recalcitrant drug offender who assaulted 2 cops with stun device Singapore 4 taken to hospital after accident near Sports Hub, including 2 rescued with hydraulic tools Singapore SG60: Many hands behind Singapore's success story We even invite ChatGPT to be a 'guest' in this podcast discussion. Highlights (click/tap above): 6:00 How can youths use ChatGPT without becoming lazy 15:21 Cognitive functions like memory and concentration have been going down: Cheryl 29:04 How young people can use Gen AI to improve critical thinking 33:42 How school curriculum can change to enhance critical thinking skills using ChatGPT 37:03 How Shahrman uses Gen AI like ChatGPT to get his colleagues to produce creative work Host: Lynda Hong ( lyndahong@ ) Produced and edited by: Hadyu Rahim, Rebekah Chia and Natasha Liew Executive producers: Ernest Luis & Lynda Hong Follow In Your Opinion Podcast here and get notified for new episode drops: Channel: Apple Podcasts: Spotify: Feedback to: podcast@ SPH Awedio app: --- Follow more ST podcast channels: All-in-one ST Podcasts channel: Get more updates: The Usual Place Podcast YouTube: --- Get The Straits Times app, which has a dedicated podcast player section: The App Store: Google Play: ---
Business Times
44 minutes ago
- Business Times
Singapore's KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle
[SINGAPORE] Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, with the Singapore International Commercial Court (SICC) having dismissed its application on Tuesday (Aug 12). The worldwide freezing order had been obtained by Danish drugmaker Novo Nordisk, which is claiming up to S$830 million in damages from KPB, over allegations that the Singapore-based biotech firm had misled it about a drug for hypertension and kidney disease. Novo Nordisk had acquired the drug from KBP in late 2023 in a deal worth up to US$1.3 billion. But less than a year later, the pharmaceutical giant halted clinical trials because the treatment was proven to be ineffective. Novo Nordisk, best known for Ozempic, the blockbuster diabetes drug, subsequently announced an impairment loss of around US$800 million. In February, Judge Philip Jeyaretnam granted the worldwide freezing order in support of the suit, which is being arbitrated in New York. The judge determined there was a real risk that KBP would place its assets beyond Novo's legal reach. Transfers of US$339.1 million from KBP to its holding company, as well as US$578.5 million paid out in dividends, indicate that its founder, Huang Zhenhua, had the intention of moving assets out of Novo's reach in anticipation of a claim, he said. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up The freeze encompasses KBP's Singapore-based assets, which include the company's DBS fixed deposit account containing US$218 million as of Dec 31, 2023, and Huang's Sennett Estate property, valued at US$7 million at purchase. The case at hand KPB had sought to set aside the freeze order on four main grounds: It argued that Novo lacked a strong legal case, and that there was no real risk of asset misuse; it further argued that Novo had failed to provide full and frank disclosure of the freeze order. The company's lawyers also contended that the application did not satisfy the legal requirements under Section 12A of the International Arbitration Act 1994, which allows the Court to grant interim measures supporting international arbitration proceedings. But in his judgement, Judge Jeyaratnam found that Novo had a good arguable case, as the evidence sufficiently established that both KBP and Huang had misled it on the efficacy of its kidney-disease drug. He also ruled that the risk that KBP and Huang would move the assets out of Novo's reach was real. The monies Huang received have remained in his personal bank accounts. But when viewed in the context of Novo's lawsuit against KBP, these funds were found to have passed through multiple intermediaries before reaching him. The evidence thus suggested that Huang had expected Novo to file claims against KBP, but not against him personally. As for whether Novo's application fulfilled Section 12A, the judge said the requirements were established as the emergency arbitrator could not grant the freezing order, which was sought without notifying the other party to prevent asset transfers. For these and other reasons, the Court declined to set aside the freeze order. Who is KBP's founder Huang Zhenhua? The native of Shandong, China, now a Singaporean citizen, has been described in the media as a 'serial entrepreneur', with more than 20 years' experience in drug research and development. After earning his PhD from Shenyang Pharmaceutical University, he founded Xuanzhu Biopharm in 2002. A decade later, he sold it to Sihuan Pharmaceutical Holdings. He served as executive director and shareholder at Sihuan before it delisted from the SGX in 2009 and then relisted in Hong Kong the following year. Huang established KBP in 2011 in Shandong. Court documents show he owns a 40 per cent stake in the company, now incorporated in Singapore, with its global headquarters in International Plaza on Anson Road, and its operations in China and the US.
Business Times
44 minutes ago
- Business Times
GoTo posts fourth straight adjusted profit, helped by cost cuts
[SINGAPORE] Indonesia's GoTo Group notched a fourth consecutive quarter of adjusted profit, making progress with reining in expenses and boosting revenue amid stiff competition in ride-hailing and delivery. Adjusted earnings before interest, taxes, depreciation and amortization were 427 billion rupiah (US$26 million) for the second quarter, GoTo said in a statement on Wednesday (Aug 13). That compares with a pro-forma loss of 64 billion rupiah a year earlier. Net revenue, which excludes incentives to driver and merchant partners and promotions to users, climbed 23 per cent on a pro forma basis to 4.3 trillion rupiah. GoTo has been making strides in its effort to cut costs and prove to investors it can make money. The company has slashed jobs and shuttered business units as user growth cools and competition from Singapore's Grab Holdings and smaller regional rivals weighs on margins. Investors remain cautious, with GoTo's stock price down about 80 per cent since it went public in Jakarta in 2022. Still, the shares have advanced more than 20 per cent over the past 12 months as GoTo's earnings have showed signs of improvement. In a move that would upend the regional market, Grab has been weighing a takeover of GoTo at a valuation of more than US$7 billion, Bloomberg News reported. Still, Grab has played down a potential deal, saying in June it's not in talks to buy GoTo 'at this time.' 'GoTo's e-commerce, once a key top-line driver, has taken a back seat after it sold 75 per cent of that business to ByteDance's TikTok Shop. GoTo earns e-commerce fees from that deal at no incremental costs,' said Nathan Naidu, analyst for Bloomberg Intelligence. 'Fintech should expand more as a closer tie-up with TikTok fuels its buy now, pay later loans, while it continues to lead in Indonesian on-demand services.' In a bid to accelerate cost savings, GoTo handed over its loss-making e-commerce unit Tokopedia to ByteDance's TikTok in a US$1.5 billion deal. The company also exited Vietnam to concentrate on achieving profitability in its core markets of Indonesia and Singapore, while pushing into growth areas like consumer lending. The company reaffirmed it expects to post adjusted Ebitda of as much as 1.6 trillion rupiah for the full year. BLOOMBERG
